Search

everythinglearnresearchcommunity

for

Search:↓

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

Lower adiponectin levels are linked to higher insulin resistance in women with PCOS.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

Platelet-rich plasma helps protect and improve ovarian function in rats treated with cyclophosphamide.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Lower SHBG levels may increase the risk of PCOS.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Low androgen levels can still cause female pattern hair loss.

Women with PCOS have higher levels of thyroid autoantibodies.

A postmenopausal woman's high testosterone levels and symptoms improved after removing a tumor from her ovary.

Reducing iron levels didn't improve heart health or metabolism in women with certain ovarian issues.

Early NAS level changes affect alcohol consumption vulnerability.

Both types of Platelet-Rich Plasma treatments work well for hair loss.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

High levels of cortisol in hair show long-term stress which can lower fertility in animals.

Finasteride safely lowers DHT levels without affecting testosterone.

PRP injections did not significantly improve ovarian function in women with low ovarian reserve.

Finasteride doesn't affect hormone levels in normal men.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Higher free testosterone levels in men are linked to a stronger immune response, not weaker.

Men and women have different levels and production of brain steroids, which may affect their risk for certain brain disorders.

Brothers of women with PCOS tend to have higher levels of a hormone called DHEAS, indicating a possible genetic link.

Changes in SHBG levels don't predict diabetes risk reduction.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

PRP shows promise in healing and regeneration but needs standardized protocols for consistent results.